# DeepEn

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/deepen

- Industry: Biotechnology
- Headquarters: Jena, Germany
- Website: www.deepen-imaging.com/
- Latest round: Seed (Feb 17, 2025)
- Investors on record: 4

## About

DeepEn GmbH is an innovative company specializing in advanced microendoscopy technology, providing efficient deep-tissue imaging solutions for biomedical research and neuroscience applications.

DeepEn GmbH, founded in 2024 in Jena, Germany, focuses on advanced microendoscopy technology. The company has not undergone any significant pivots or changes in business operations since its inception. The founder’s history is not specified. DeepEn GmbH has completed a total of 1 deal, with its most recent deal occurring on February 18, 2025. The company raised EUR 2.5 million in its Seed funding round from investors including Bm|t, EIC Ltd., Mittelstandische Beteiligungsgesellschaft Thuringen, and Sparkasse Jena-Saale-Holzland.

DeepEn GmbH specializes in advanced microendoscopy technology, specifically through its NeuroDeep platform, which offers minimally invasive deep-tissue imaging solutions. The company's core product is an ultrathin holographic endoscope that allows for intravital microscopy via a single multimode fibre probe with a diameter of only 100 µm. This technology facilitates high-resolution imaging of neuronal structures, including axons and dendritic spines, enabling research into neuronal plasticity and connectivity. The NeuroDeep platform employs advanced holographic imaging techniques to achieve submicrometric lateral resolution and rapid read-out speeds of up to 25,000 focal points per second, addressing complex biomedical research needs. DeepEn's products primarily serve neuroscience and biomedical research sectors, catering to academic institutions and pharmaceutical laboratories across Europe and North America, where researchers require advanced imaging tools for studying brain disorders and dynamics.

DeepEn generates revenue through direct sales of its NeuroDeep microendoscopy systems to research institutions and pharmaceutical companies. The transaction structure is primarily B2B, with potential partnerships for collaborative research and development projects. Clients engage in purchasing the holographic endoscopes and associated services, which may include training and support for effective utilization in laboratory settings. While specific pricing plans are not disclosed, the company’s offerings are geared towards high-value research applications, reflecting the sophisticated nature of the technology. The company aims to establish long-term relationships with clients by providing continuous innovation in imaging solutions, thereby enhancing their capabilities in neuroscience research and applications.

In February 2025, DeepEn GmbH raised EUR 2.5 million in Seed funding to support the research of its biotechnology development. The company plans to expand its product offerings by designing new imaging solutions targeted for release in the next 18 months. Additionally, DeepEn aims to enter new markets, specifically targeting increased presence in North American academic research institutions by the end of 2026. The recent funding will be utilized to bolster these initiatives and enhance research capabilities.

## Funding rounds

- Seed, Feb 17, 2025 — EIC Ltd., Bm|t, Mittelstandische Beteiligungsgesellschaft Thuringen, Sparkasse Jena-Saale-Holzland

## Investors

- EIC Ltd. — Seed
- Bm|t — Seed
- Mittelstandische Beteiligungsgesellschaft Thuringen (https://capitalatlas.ai/funds/mittelstandische-beteiligungsgesellschaft-thuringen) — Seed
- Sparkasse Jena-Saale-Holzland — Seed